ES2145221T3 - Procedimiento para preparar nizatidina pura. - Google Patents
Procedimiento para preparar nizatidina pura.Info
- Publication number
- ES2145221T3 ES2145221T3 ES95306049T ES95306049T ES2145221T3 ES 2145221 T3 ES2145221 T3 ES 2145221T3 ES 95306049 T ES95306049 T ES 95306049T ES 95306049 T ES95306049 T ES 95306049T ES 2145221 T3 ES2145221 T3 ES 2145221T3
- Authority
- ES
- Spain
- Prior art keywords
- nizatidine
- procedure
- preparing pure
- pure
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 title abstract 3
- 229960004872 nizatidine Drugs 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000009965 odorless effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
LA PRESENTE INVENCION PROPORCIONA UNA COMPOSICION FARMACEUTICA INOLORA DE NIZATIDINA. TAMBIEN PROPORCIONA UNA FORMA DE NIZATIDINA PURA Y UN PROCESO PARA LA PREPARACION DE LA MISMA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/298,486 US5470865A (en) | 1994-08-30 | 1994-08-30 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2145221T3 true ES2145221T3 (es) | 2000-07-01 |
Family
ID=23150736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95306049T Expired - Lifetime ES2145221T3 (es) | 1994-08-30 | 1995-08-30 | Procedimiento para preparar nizatidina pura. |
Country Status (24)
Country | Link |
---|---|
US (1) | US5470865A (es) |
EP (1) | EP0704214B1 (es) |
JP (1) | JPH0892087A (es) |
KR (1) | KR960006921A (es) |
CN (1) | CN1127635A (es) |
AT (1) | ATE192039T1 (es) |
AU (1) | AU700488B2 (es) |
BR (1) | BR9503832A (es) |
CA (1) | CA2157240A1 (es) |
CO (1) | CO4410183A1 (es) |
CZ (1) | CZ189395A3 (es) |
DE (1) | DE69516475T2 (es) |
ES (1) | ES2145221T3 (es) |
FI (1) | FI954050A (es) |
HU (1) | HUT72672A (es) |
IL (1) | IL115012A0 (es) |
NO (1) | NO952825L (es) |
NZ (1) | NZ272833A (es) |
PE (1) | PE33696A1 (es) |
PH (1) | PH31452A (es) |
PL (1) | PL310207A1 (es) |
TR (1) | TR199500885A2 (es) |
YU (1) | YU57495A (es) |
ZA (1) | ZA957281B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010068707A (ko) * | 2000-01-07 | 2001-07-23 | 최용준 | 시계줄 |
JP2001240534A (ja) * | 2000-02-29 | 2001-09-04 | Bio Kagaku Kk | 液状組成物 |
KR102178793B1 (ko) * | 2019-04-17 | 2020-11-13 | 황용석 | 순금 장식연결구 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4375547A (en) * | 1980-10-02 | 1983-03-01 | Eli Lilly And Company | N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine |
US4382090A (en) * | 1980-10-02 | 1983-05-03 | Eli Lilly And Company | N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds |
US4760075A (en) * | 1980-10-02 | 1988-07-26 | Eli Lilly And Company | N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds |
US4904792A (en) * | 1980-10-02 | 1990-02-27 | Eli Lilly And Company | N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds |
ES8601941A1 (es) * | 1983-02-07 | 1985-11-01 | Lilly Co Eli | Un procedimiento para la preparacion de nizatidina |
US4587344A (en) * | 1983-02-07 | 1986-05-06 | Eli Lilly And Company | Isothiourea synthesis process |
US4777260A (en) * | 1985-12-18 | 1988-10-11 | Eli Lilly And Company | Synthesis of nizatidine intermediate |
EP0230127A1 (en) * | 1985-12-18 | 1987-07-29 | Eli Lilly And Company | Synthesis of nizatidine |
US4857344A (en) | 1986-12-31 | 1989-08-15 | Del Monte Corporation | Method for treating pineapple to inhibit browning |
EP0285681B1 (de) * | 1987-04-06 | 1993-03-10 | HEUMANN PHARMA GMBH & CO | Verfahren zur Herstellung von Nitroethenderivaten |
EP0396830B1 (en) * | 1989-05-10 | 1993-10-27 | Council of Scientific and Industrial Research | An improved process for the preparation of 1-substituted amino-1-substituted thio-2-nitro alkenes |
US5075114A (en) * | 1990-05-23 | 1991-12-24 | Mcneil-Ppc, Inc. | Taste masking and sustained release coatings for pharmaceuticals |
CA2055661A1 (en) * | 1990-12-21 | 1992-06-22 | Manley A. Paulos | Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation |
US5334725A (en) * | 1991-05-21 | 1994-08-02 | Eli Lilly And Company | 2-aminomethyl-4-exomethylenethiazoline epoxides |
US5503846A (en) * | 1993-03-17 | 1996-04-02 | Cima Labs, Inc. | Base coated acid particles and effervescent formulation incorporating same |
-
1994
- 1994-08-30 US US08/298,486 patent/US5470865A/en not_active Expired - Lifetime
-
1995
- 1995-07-14 CO CO95031236A patent/CO4410183A1/es unknown
- 1995-07-14 PE PE1995273860A patent/PE33696A1/es not_active Application Discontinuation
- 1995-07-17 NO NO952825A patent/NO952825L/no unknown
- 1995-07-20 CZ CZ951893A patent/CZ189395A3/cs unknown
- 1995-07-20 TR TR95/00885A patent/TR199500885A2/xx unknown
- 1995-08-21 IL IL11501295A patent/IL115012A0/xx unknown
- 1995-08-23 NZ NZ272833A patent/NZ272833A/en unknown
- 1995-08-28 PL PL95310207A patent/PL310207A1/xx unknown
- 1995-08-29 YU YU57495A patent/YU57495A/sh unknown
- 1995-08-29 FI FI954050A patent/FI954050A/fi unknown
- 1995-08-29 BR BR9503832A patent/BR9503832A/pt not_active Application Discontinuation
- 1995-08-29 AU AU30334/95A patent/AU700488B2/en not_active Ceased
- 1995-08-29 KR KR1019950027004A patent/KR960006921A/ko not_active Application Discontinuation
- 1995-08-30 JP JP7221564A patent/JPH0892087A/ja active Pending
- 1995-08-30 CA CA002157240A patent/CA2157240A1/en not_active Abandoned
- 1995-08-30 CN CN95116919A patent/CN1127635A/zh active Pending
- 1995-08-30 PH PH51217A patent/PH31452A/en unknown
- 1995-08-30 HU HU9502542A patent/HUT72672A/hu unknown
- 1995-08-30 ZA ZA957281A patent/ZA957281B/xx unknown
- 1995-08-30 AT AT95306049T patent/ATE192039T1/de not_active IP Right Cessation
- 1995-08-30 EP EP95306049A patent/EP0704214B1/en not_active Expired - Lifetime
- 1995-08-30 ES ES95306049T patent/ES2145221T3/es not_active Expired - Lifetime
- 1995-08-30 DE DE69516475T patent/DE69516475T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2157240A1 (en) | 1996-03-01 |
CN1127635A (zh) | 1996-07-31 |
DE69516475T2 (de) | 2000-09-28 |
KR960006921A (ko) | 1996-03-22 |
FI954050A0 (fi) | 1995-08-29 |
CO4410183A1 (es) | 1997-01-09 |
BR9503832A (pt) | 1996-09-10 |
EP0704214A1 (en) | 1996-04-03 |
HUT72672A (en) | 1996-05-28 |
FI954050A (fi) | 1996-03-02 |
AU3033495A (en) | 1996-03-14 |
ATE192039T1 (de) | 2000-05-15 |
PH31452A (en) | 1998-11-03 |
TR199500885A2 (tr) | 1996-06-21 |
HU9502542D0 (en) | 1995-10-30 |
US5470865A (en) | 1995-11-28 |
NZ272833A (en) | 1997-04-24 |
ZA957281B (en) | 1997-02-28 |
PL310207A1 (en) | 1996-03-04 |
NO952825D0 (no) | 1995-07-17 |
PE33696A1 (es) | 1996-08-29 |
JPH0892087A (ja) | 1996-04-09 |
CZ189395A3 (en) | 1996-03-13 |
NO952825L (no) | 1996-03-01 |
DE69516475D1 (de) | 2000-05-31 |
IL115012A0 (en) | 1996-01-31 |
EP0704214B1 (en) | 2000-04-26 |
YU57495A (sh) | 1999-07-28 |
AU700488B2 (en) | 1999-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0115482A (pt) | Composição de sacralose melhorada e processo para sua preparação | |
PT758248E (pt) | Formulacoes para o factor ix | |
HN1997000072A (es) | Procedimiento para la preparacion de sildenafil | |
PT915898E (pt) | Forma i cristalina de claritromicina | |
TR199901077A2 (en) | �spen�iyari form�lasyonlar. | |
MY107158A (en) | 3-arylcarbonyl; -1h-indoles useful as therapeutic agents. | |
SE9704545D0 (sv) | Novel compounds | |
ES2121366T3 (es) | Nuevos fosfolipidos cationicos para transfeccion. | |
NO905428L (no) | Fremgangsmaate for fremstilling av hiv-proteaseinhibitorerfor behandling av aids. | |
NO954427D0 (no) | Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS | |
SE9704546D0 (sv) | Novel compounds | |
AR032293A1 (es) | Estuche farmaceutico | |
ES2144239T3 (es) | Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos. | |
ES2166051T3 (es) | Productos intermedios y procedimiento para preparar olanzapina. | |
ES2145221T3 (es) | Procedimiento para preparar nizatidina pura. | |
MY127474A (en) | Naphthyl compounds, intermediates, compositions, and methods of use | |
ES2185196T3 (es) | Un procedimiento para la preparacion de tetraazamacrociclos. | |
ES2172182T3 (es) | Composiciones farmaceuticas que comprenden cefuroxima axetil. | |
NZ515685A (en) | Use of riluzole for the treatment of multiple sclerosis | |
BR0016941A (pt) | Derivados de aminometil-fenil-ciclohexanona | |
EA200000112A1 (ru) | Новая композиция | |
NO20005548L (no) | Mykobakterieinhibitorer | |
FI964446A0 (fi) | Uusia tetrapeptidejä, niiden valmistus ja käyttö | |
NO905003D0 (no) | Fremgangsmaate for fremstilling av proteaseinhibitorer frapotetsaft. | |
AR018321A1 (es) | Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 704214 Country of ref document: ES |